Area of research
Surgery · Endocrinology, Diabetes and Metabolism
Research interest
Research interests include Lipoproteins and Cardiovascular Health, Diabetes, Cardiovascular Risks, and Lipoproteins, Cancer, Lipids, and Metabolism, and Lipid metabolism and disorders.
Association of cardiovascular risk scores with coronary plaque and its progression among individuals with family history of coronary artery disease.
Association of leukocyte count with atherosclerotic cardiovascular disease in patients with genetically defined familial hypercholesterolaemia.
Attainment of Low-Density Lipoprotein Cholesterol Goals and Statin Use in Patients With Atherosclerotic Cardiovascular Disease in Australian General Practice: Are We Doing Enough?
Barriers and Facilitators to Implementing Guideline Recommendations for Key Aspects of Familial Hypercholesterolemia Management in Australia: Primary Care Integration, Paediatric Management, and Treatment Adherence.
Challenges in the care of women with familial hypercholesterolaemia during the reproductive period - current evidence and practical guidance.
Implementation strategies for improving the care of familial hypercholesterolaemia from the International Atherosclerosis Society: next steps in implementation science and practice
Assessment of metabolic dysfunction‐associated fatty liver disease in primary care: a consensus statement summary
Plozasiran for Managing Persistent Chylomicronemia and Pancreatitis Risk
Palisade: Plozasiran decreases the risk of Acute Pancreatitis (AP) and may improve Quality of Life (QOL) in Familial Chylomicronemia Syndrome (FCS)
Plozasiran (ARO-APOC3) for Severe Hypertriglyceridemia
Synovial fibroblast gene expression is associated with sensory nerve growth and pain in rheumatoid arthritis
Tissue-specific enhancer–gene maps from multimodal single-cell data identify causal disease alleles
The chromatin landscape of pathogenic transcriptional cell states in rheumatoid arthritis
Lipidomic Risk Score to Enhance Cardiovascular Risk Stratification for Primary Prevention
Adipocyte associated glucocorticoid signaling regulates normal fibroblast function which is lost in inflammatory arthritis
Automated multi-scale computational pathotyping (AMSCP) of inflamed synovial tissue
Temporal Effects of Plozasiran on Lipids and Lipoproteins in Persistent Chylomicronemia
Zodasiran silences hepatic ANGPTL3 leading to deep and durable reductions in atherogenic lipids and lipoproteins in mixed dyslipidemia patients: Final results from arches-2, double-blind period
Deconstruction of rheumatoid arthritis synovium defines inflammatory subtypes
2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance
International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia
Frequent questions and responses on the 2022 lipoprotein(a) consensus statement of the European Atherosclerosis Society
RNA Interference Therapy Targeting Apolipoprotein C-III in Hypertriglyceridemia
Mapping the dynamic genetic regulatory architecture of HLA genes at single-cell resolution
Australian Atherosclerosis Society Position Statement on Lipoprotein(a): Clinical and Implementation Recommendations
Combined population genomic screening for three high-risk conditions in Australia: a modelling study
Zhang, R. (Creator), Ng, J. (Creator), Lim, E. M. (Creator), Beilby, J. (Creator), Watts, G. (Creator) & Stuckey, B. (Creator), The University of Western Australia, 16 May 2023
— 2023cited by 0position: selected
Brown, S. (Creator), Ng, J. (Creator), Watts, G. (Creator), Stuckey, B. (Creator), Beilby, J. (Creator), Lim, E. M. (Creator) & Zhang, R. (Creator), The University of Western Australia, 10 May 2023
— 2023cited by 0position: selected
Brown, S. (Creator), Ng, J. (Creator), Stuckey, B. (Creator), Watts, G. (Creator), Beilby, J. (Creator), Lim, E. M. (Creator), Zhang, R. (Creator) & Brown, S. J. (Creator), The University of Western Australia, 10 May 2023
— 2023cited by 0position: selected
Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement